ATE67091T1 - Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis. - Google Patents

Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.

Info

Publication number
ATE67091T1
ATE67091T1 AT86300720T AT86300720T ATE67091T1 AT E67091 T1 ATE67091 T1 AT E67091T1 AT 86300720 T AT86300720 T AT 86300720T AT 86300720 T AT86300720 T AT 86300720T AT E67091 T1 ATE67091 T1 AT E67091T1
Authority
AT
Austria
Prior art keywords
manufacture
treatment
drug
viral hepatitis
hepatitis
Prior art date
Application number
AT86300720T
Other languages
English (en)
Inventor
Irving Millman
Pinayur S Venkateswaran
Baruch S Blumberg
Original Assignee
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Center filed Critical Fox Chase Cancer Center
Application granted granted Critical
Publication of ATE67091T1 publication Critical patent/ATE67091T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT86300720T 1985-04-26 1986-02-03 Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis. ATE67091T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/727,452 US4673575A (en) 1985-04-26 1985-04-26 Composition, pharmaceutical preparation and method for treating viral hepatitus
EP19860300720 EP0199429B1 (de) 1985-04-26 1986-02-03 Herstellung eines Arzneimittels für die Behandlung von viraler Hepatitis

Publications (1)

Publication Number Publication Date
ATE67091T1 true ATE67091T1 (de) 1991-09-15

Family

ID=24922713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86300720T ATE67091T1 (de) 1985-04-26 1986-02-03 Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.

Country Status (6)

Country Link
US (1) US4673575A (de)
EP (1) EP0199429B1 (de)
AT (1) ATE67091T1 (de)
AU (1) AU593547B2 (de)
CA (1) CA1268712A (de)
DE (1) DE3681323D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937074A (en) * 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
GB2331460B (en) * 1996-08-16 1999-12-22 Hepaguard Co Ltd Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria
DE69718156T2 (de) * 1997-04-21 2003-11-06 Dabur Res Foundation Sahibabad Polypflanzliche pharmazeutische Zusammensetzungen geeignet in der Behandlung der Hepatitis E und Hepatitis B Virus-Infektion zusammenhängenden Zustände
WO2000010991A1 (en) 1998-08-25 2000-03-02 Yale University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
WO2000056347A1 (en) * 1999-03-24 2000-09-28 Southern Petrochemical Industries Corporation Limited An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
DE10014674B4 (de) * 2000-03-24 2005-01-27 Council Of Scientific And Industrial Research (C.S.I.R.) Verfahren für die Extraktion und Isolierung von Phyllanthin
CA2424930A1 (en) * 2000-10-06 2003-04-04 Cmi-Centers For Medical Innovation Ag Method for producing phyllanthus extracts
ES2261507T3 (es) * 2000-10-06 2006-11-16 Phytrix Inc. Compuestos derivados de phyllanthus para la prevencion y/o el tratamiento de enfermedades asociadas con un retrovirus.
DE10120627A1 (de) * 2001-04-26 2002-10-31 Cmi Ag Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren
DE10155517A1 (de) * 2001-11-13 2003-05-28 Metanomics Gmbh & Co Kgaa Verfahren zur Extraktion von Inhaltsstoffen aus organischem Material

Also Published As

Publication number Publication date
AU5653086A (en) 1986-10-30
EP0199429A2 (de) 1986-10-29
EP0199429A3 (en) 1988-02-24
AU593547B2 (en) 1990-02-15
DE3681323D1 (de) 1991-10-17
EP0199429B1 (de) 1991-09-11
CA1268712A (en) 1990-05-08
US4673575A (en) 1987-06-16

Similar Documents

Publication Publication Date Title
ATE67091T1 (de) Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.
IT1062511B (it) Metodo e composizione per rimuovere il virus dell'epatite da materiali biologici
NL186239C (nl) Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK0662157T3 (da) Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme
CA2221370A1 (en) Composition for treating condyloma acuminata
NL7702784A (nl) Werkwijze voor het zuiveren en isoleren van he- patitisvirus ten gebruike bij de bereiding van een vaccin.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DE3174807D1 (en) Pharmaceutical composition
ATE87484T1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE70184T1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
DK430989D0 (da) Transdermalt anvendeligt laegemiddel med et indhold af farmaceutisk anvendelige glykosider
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
WO1990013281A3 (en) Method of suppressing hiv infection
US6428819B1 (en) Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
FI100769B (fi) Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi
DE59000712D1 (de) Extrakt arzneimittel.
JPS5247980A (en) Method of preparing new nuclease
Matsueda et al. Therapeutical effect of chlorella to human serum pseudocholinesterase.
JP2002533400A5 (de)
ATE302944T1 (de) Verfahren zum screening von arzneizubereitungen
TAKAHASHI et al. Synthesis of Host Ribosomal RNA's in Tabacco Leaves Inoculated with Tobacco Mosaic Virus
JPS5731619A (en) Improver for liver function
DE3886526D1 (de) Mittel zur verhinderung der progredienz der erkrankung nach hiv-virusinfektionen.
RU2004100875A (ru) Средство для профилактики вирусного гепатита c
IT1277118B1 (it) Composizioni farmaceutiche per il trattamento delle epatopatie croniche

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties